Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Helix Biotech Biosimilar mRNA Vaccines

UK Health Security Agency

This public procurement record has 2 releases in its history.

TenderCancellation

04 Sep 2025 at 13:41

UK12 - Procurement Termination Notice
Award

12 Aug 2025 at 10:18

UK5 - Transparency Notice
Summary of the contracting process

The procurement process, led by the UK Health Security Agency, centred around the provision of biosimilar mRNA vaccines, specifically focusing on industry advancements in biotechnology. The buying organisation, a central government public authority, is located at 10 South Colonnade in London, United Kingdom. Initially, a direct award strategy was employed with Helix Biotech Inc., situated in Tennessee, USA. This direct procurement was chosen due to the unique capabilities of Helix Biotech in supplying vaccine mimic materials equivalent to existing licensed vaccines. The contract, awarded on 12th August 2025, is now in a completed status, although a tender cancellation notice was subsequently issued on 4th September 2025 to enable a revised transparency notice. The contract period is set from 8th September 2025 to 7th September 2027.

This tender represents a significant growth opportunity for businesses involved in the biosimilars and vaccine manufacturing sectors. Companies possessing innovative biotechnology solutions or those able to offer novel biopharmaceutical ingredients would find themselves particularly suited to compete in this sphere. Additionally, businesses with existing capabilities that include mRNA technology and lipid nanoparticle formulation are well positioned to take advantage of direct procurement methods employed by government entities, ensuring swift entry and operational benefits in this rapidly evolving industry. This contract underscores the potential for further collaborations with public health agencies looking to secure strategic resources aligned with contemporary health security needs.

How relevant is this notice?

Notice Information

Notice Title

Helix Biotech Biosimilar mRNA Vaccines

Notice Description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

Procurement Information

Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0585bd
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/053927-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
SME, VCSE
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£150,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
4 Sep 202511 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
12 Aug 20251 years ago
Contract Period
8 Sep 2025 - 7 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Cancelled
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK Health Security Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

Helix Biotech, Inc.

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...